| scholarly article | Q13442814 |
| P50 | author | Perry F Renshaw | Q87441912 |
| P2093 | author name string | Douglas G Kondo | |
| Tracy L Hellem | |||
| Xianfeng Shi | |||
| Young-Hoon Sung | |||
| Rebekah S Huber | |||
| Lauren N Forrest | |||
| P2860 | cites work | The concentration of creatine in meat, offal and commercial dog food. | Q55067027 |
| Involvement of PKA, PKC, CAMK-II and MEK1/2 in the acute antidepressant-like effect of creatine in mice. | Q55073616 | ||
| A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity | Q55879648 | ||
| Depression in young people: initial presentation and clinical course | Q72854491 | ||
| Frontal lobe in vivo (31)P-MRS reveals gender differences in healthy controls, not in schizophrenics | Q73431741 | ||
| Efficacy of antidepressants in juvenile depression: meta-analysis | Q22255557 | ||
| Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis | Q24527330 | ||
| The creatine kinase system and pleiotropic effects of creatine | Q24609852 | ||
| Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? | Q24631151 | ||
| Pharmacological approaches to the challenge of treatment-resistant depression | Q26798241 | ||
| The neural effects of psychotropic medications in children and adolescents | Q26850357 | ||
| Systematic review of management for treatment-resistant depression in adolescents | Q26865021 | ||
| Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A) | Q28111792 | ||
| Sex differences in mitochondrial (dys)function: Implications for neuroprotection | Q28386911 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
| Chronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats. | Q30389926 | ||
| Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate | Q30810394 | ||
| 31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression? | Q30812485 | ||
| Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study | Q31878568 | ||
| Advanced In Vivo Heteronuclear MRS Approaches for Studying Brain Bioenergetics Driven by Mitochondria | Q33374303 | ||
| Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys | Q33604829 | ||
| Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats | Q33771249 | ||
| Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder | Q33783427 | ||
| Evidence for the management of adolescent depression. | Q33819692 | ||
| Gender differences in unipolar depression: an update of epidemiological findings and possible explanations | Q34218386 | ||
| A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder | Q34292341 | ||
| Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial | Q34341755 | ||
| Psychometric properties of the Children's Depression Rating Scale-Revised in adolescents | Q34413013 | ||
| Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment | Q34454744 | ||
| Mitochondrial creatine kinase in human health and disease | Q34461137 | ||
| Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder | Q34587328 | ||
| A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis | Q34610044 | ||
| Practice parameter for the assessment and treatment of children and adolescents with depressive disorders | Q34720078 | ||
| Stress, sensitive periods and maturational events in adolescent depression | Q34760313 | ||
| Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. | Q35040553 | ||
| The increasing burden of depression | Q35090232 | ||
| Measurement of creatine kinase reaction rate in human brain using magnetization transfer image-selected in vivo spectroscopy (MT-ISIS) and a volume ³¹P/¹H radiofrequency coil in a clinical 3-T MRI system | Q35126978 | ||
| Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation | Q35587857 | ||
| The NIMH experimental medicine initiative | Q35754731 | ||
| Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study | Q36271087 | ||
| Optimizing early Go/No Go decisions in CNS drug development | Q36288836 | ||
| Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study | Q36387048 | ||
| Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial | Q36514240 | ||
| Cerebral energetic effects of creatine supplementation in humans | Q36603260 | ||
| Correlation, regression, and repeated data | Q36749064 | ||
| Creatine: endogenous metabolite, dietary, and therapeutic supplement | Q36789361 | ||
| Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data | Q36888585 | ||
| The ABCs of depression: integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression | Q37143464 | ||
| Functions and effects of creatine in the central nervous system. | Q37172733 | ||
| Expression and function of AGAT, GAMT and CT1 in the mammalian brain | Q37225751 | ||
| Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. | Q37480270 | ||
| Sex, trauma, stress hormones and depression | Q37601945 | ||
| Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review | Q37683984 | ||
| Update on the use of MR for assessment and diagnosis of psychiatric diseases | Q37716336 | ||
| Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders | Q37778476 | ||
| Impaired mitochondrial function in psychiatric disorders | Q38003304 | ||
| A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. | Q38208786 | ||
| A mitochondrial bioenergetic basis of depression | Q38254909 | ||
| Creatine as a booster for human brain function. How might it work? | Q38571612 | ||
| Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults | Q40283412 | ||
| Comparative quantification of dietary supplemented neural creatine concentrations with (1)H-MRS peak fitting and basis spectrum methods. | Q40790278 | ||
| Presentation and course of major depressive disorder during childhood and later years of the life span | Q41017525 | ||
| Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations | Q41168227 | ||
| The modulation of NMDA receptors and L-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test. | Q41630586 | ||
| Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study | Q42165444 | ||
| Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy | Q43737909 | ||
| Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression | Q43812681 | ||
| Puberty and depression: the roles of age, pubertal status and pubertal timing | Q44075236 | ||
| Sexual dimorphism in rat cerebrum and cerebellum: different patterns of catalytically active creatine kinase isoenzymes during postnatal development and aging | Q44277445 | ||
| Analog classroom assessment of Adderall in children with ADHD. | Q44382273 | ||
| Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. | Q44438162 | ||
| Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis | Q44971585 | ||
| Brain region- and sex-specific modulation of mitochondrial glucocorticoid receptor phosphorylation in fluoxetine treated stressed rats: effects on energy metabolism | Q45297040 | ||
| A pilot dose-finding clinical trial of creatine monohydrate augmentation to SSRIs/SNRIs/NASA antidepressant treatment in major depression | Q45331177 | ||
| STAR*D: revising conventional wisdom. | Q45931500 | ||
| Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression. | Q45946184 | ||
| Creatine monohydrate in resistant depression: a preliminary study | Q46910762 | ||
| Suicidality in pediatric patients treated with antidepressant drugs | Q46977975 | ||
| The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity | Q47915818 | ||
| Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine. | Q48083788 | ||
| Increase of total creatine in human brain after oral supplementation of creatine-monohydrate | Q48114355 | ||
| 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients | Q48293704 | ||
| Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity. | Q48583660 | ||
| Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study | Q48823084 | ||
| Brain creatine depletion in vegetarians? A cross-sectional ¹H-magnetic resonance spectroscopy (¹H-MRS) study | Q48832841 | ||
| Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: the CRESCEND study | Q48932584 | ||
| National Institute of Mental Health clinical trials: new opportunities, new expectations. | Q50644922 | ||
| Emergence of gender differences in depression during adolescence: national panel results from three countries. | Q50691155 | ||
| Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. | Q50856088 | ||
| Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study | Q50902337 | ||
| Estimating correlation coefficient between two variables with repeated observations using mixed effects model. | Q51941505 | ||
| Effect of phosphomonoesters, phosphodiesters, and phosphocreatine on glutamate uptake by synaptic vesicles. | Q52191375 | ||
| Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression. | Q54138607 | ||
| P433 | issue | 8 | |
| P921 | main subject | teenager | Q1492760 |
| P304 | page(s) | 1941-1954 | |
| P577 | publication date | 2016-02-23 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression | |
| P478 | volume | 48 |
| Q47695444 | A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression |
| Q38645491 | An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women |
| Q92876206 | Creatine for the Treatment of Depression |
| Q55020079 | Creatine: a miserable life without it. |
| Q89747533 | Dietary creatine intake and depression risk among U.S. adults |
| Q104795025 | Differential and spatial expression meta-analysis of genes identified in genome-wide association studies of depression |
| Q47872069 | Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study |
| Q95643364 | Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators |
| Q91893883 | The Assertive Brain: Anterior Cingulate Phosphocreatine plus Creatine Levels Correlate With Self-Directedness in Healthy Adolescents |
Search more.